Disinfecting all ICU patients significantly reduces MRSA
Decolonization of all intensive care unit (ICU) patients with antimicrobial soap and ointment significantly reduces all bloodstream infections, including methicillin-resistant Staphylococcus aureus (MRSA), according to a study published in the New England Journal of Medicine.
Decolonization of all intensive care unit (ICU) patients with antimicrobial soap and ointment significantly reduces all bloodstream infections, including methicillin-resistant Staphylococcus aureus (MRSA), according to a study published in the New England Journal of Medicine.
“The REDUCE MRSA study proved that universal decolonization is the best practice to prevent infection from MRSA and other dangerous bacteria in high-risk ICU patients,” said Jonathan B. Perlin, MD, president, clinical and physician services group and chief medical officer of Hospital Corporation of America (HCA).
The study, the Randomized Evaluation of Decolonization Versus Universal Clearance to Eliminate (REDUCE) MRSA, was conducted at 43 HCA hospitals by academic investigators (the University of California Irvine School of Medicine, Harvard Medical School, Rush Medical College, Washington University in St. Louis), the Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. It involved nearly 75,000 patients in 74 adult ICUs across 16 states.
The study compared screening all patients and isolating MRSA carriers; targeted decolonization (screening, isolation, and decolonization of MRSA carriers with daily bathing with chlorhexidine and administration of intranasal mupirocin ointment twice daily for 5 days); and universally disinfecting all patients with chlorhexidine and mupirocin.
It found universal decolonization reduced MRSA infections by 37%. Targeted decolonization reduced MRSA infections by 25%; and the screening and isolation method reduced MRSA infections by 8%. Universal decolonization reduced all bloodstream infections by 44%.
The study results suggest the need for a major strategy shift in battling MRSA infections, away from targeted to universal decolonization. “Universal decolonization should be a new part of a comprehensive infection prevention effort that begins with hand hygiene and includes a number of proven practices,” Perlin said.
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
ICER Finds Insurers Struggled to Provide Fair Access for Obesity Drugs
December 19th 2024The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access for drugs that the organization had reviewed in 2022 for cost-effectiveness.
Read More
